Absci (ABSI) Assets Average (2021 - 2026)
Absci (ABSI) posted Assets Average of $205.9 million for Q1 2026, down 10.71% sequentially from $230.6 million in Q4 2025, and down 7.66% YoY from $223.0 million in Q1 2025.
Absci (ABSI) Assets Average (2021 - 2026) Analysis & Trends
Absci has reported Assets Average for 6 years, with the latest figure at $205.9 million in Q1 2026.
- Quarterly Assets Average fell 7.66% year-over-year to $205.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $205.9 million (down 7.66% YoY) and the FY2025 annual result came in at $215.0 million, changed 0.23% from the prior year.
- Assets Average retreated to $205.9 million in Q1 2026 per ABSI's latest filing, from $230.6 million in the prior quarter.
- Over five years, Assets Average peaked at $410.8 million in Q1 2022 and troughed at $205.9 million in Q1 2026.
- A 5-year average of $271.7 million and a median of $245.4 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2023 and 2025: Assets Average plunged 31.31% in 2023, then grew 2.77% in 2025.
- Over 5 years, Assets Average stood at $330.2 million in 2022, then slumped by 31.31% to $226.8 million in 2023, then dropped by 1.06% to $224.4 million in 2024, then gained by 2.77% to $230.6 million in 2025, then retreated by 10.71% to $205.9 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $205.9 million, $230.6 million, and $227.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | 232.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 232.26 Mn |
| Mar 31, 2026 | 205.95 Mn |
| Dec 31, 2025 | 230.64 Mn |
| Sep 30, 2025 | 227.44 Mn |
| Jun 30, 2025 | 221.17 Mn |
| Mar 31, 2025 | 223.03 Mn |
| Dec 31, 2024 | 224.42 Mn |
| Sep 30, 2024 | 245.38 Mn |
| Jun 30, 2024 | 265.21 Mn |
| Mar 31, 2024 | 246.10 Mn |
| Dec 31, 2023 | 226.82 Mn |
| Sep 30, 2023 | 245.25 Mn |
| Jun 30, 2023 | 274.98 Mn |
| Mar 31, 2023 | 308.41 Mn |
| Dec 31, 2022 | 330.20 Mn |
| Sep 30, 2022 | 352.85 Mn |
| Jun 30, 2022 | 380.89 Mn |
| Mar 31, 2022 | 410.83 Mn |
| Dec 31, 2021 | 437.66 Mn |
| Sep 30, 2021 | 353.09 Mn |